Toggle light / dark theme

The Biologist Blowing Our Minds

Michael Levin, a developmental biologist at Tufts University, has a knack for taking an unassuming organism and showing it’s capable of the darnedest things. He and his team once extracted skin cells from a frog embryo and cultivated them on their own. With no other cell types around, they were not “bullied,” as he put it, into forming skin tissue. Instead, they reassembled into a new organism of sorts, a “xenobot,” a coinage based on the Latin name of the frog species, Xenopus laevis. It zipped around like a paramecium in pond water. Sometimes it swept up loose skin cells and piled them until they formed their own xenobot—a type of self-replication. For Levin, it demonstrated how all living things have latent abilities. Having evolved to do one thing, they might do something completely different under the right circumstances.

Slime mold grows differently depending on the music playing.

Not long ago I met Levin at a workshop on science, technology, and Buddhism in Kathmandu. He hates flying but said this event was worth it. Even without the backdrop of the Himalayas, his scientific talk was one of the most captivating I’ve ever heard. Every slide introduced some bizarre new experiment. Butterflies retain memories from when they were caterpillars, even though their brains turned to mush in the chrysalis. Cut off the head and tail of a planarian, or flatworm, and it can grow two new heads; if you amputate again, the worm will regrow both heads. Levin argues the worm stores the new shape in its body as an electrical pattern. In fact, he thinks electrical signaling is pervasive in nature; it is not limited to neurons. Recently, Levin and colleagues found that some diseases might be cured by retraining the gene and protein networks as one might train a neural network.

Researchers discover cancer hijacks a class of enzyme motif mutations to fuel tumorigenesis

Cancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it can manipulate our genetic make-up, take over specific cell-to-cell signaling processes, and mutate key enzymes to promote tumor growth, resist therapies, and hasten its spread from the original site to the bloodstream or other organs.

Enzyme mutations have been of great interest to scientists who study . Scientists in the Liu and Tan labs at UNC’s Lineberger Comprehensive Cancer Center have been studying mutations of enzyme recognition motifs in substrates, which may more faithfully reflect with the potential to find new targets or directions for .

“We think understanding the roles of mutations on enzyme substrates, instead of the enzyme as a whole, may help to improve efficacy of targeted therapies, especially for enzymes that have both oncogenic and tumor suppressive function through controlling distinct subsets of substrates,” said Jianfeng Chen, Ph.D., who is first author and a postdoctoral fellow in the Liu lab in the UNC Department of Biochemistry and Biophysics.

Consensus recommendations for imaging of coronary artery stenosis and atherosclerosis

An interdisciplinary team of clinicians and scientists has published a consensus paper recommending appropriate quantitative imaging techniques for coronary artery stenosis and atherosclerosis related treatment and procedural planning. The paper has been published in Nature Reviews Cardiology.

Quantitative imaging has become increasingly important for the diagnosis of coronary artery disease (CAD) over the past five years. This is because new quantitative techniques can detect narrowed coronary arteries (coronary artery stenoses) and atherosclerosis, which play a major role in CHD patients.

It is important to correctly diagnose and accurately assess the severity of or the extent of atherosclerotic burden for the selection of appropriate measures of therapy and the related further course of the disease. However, the complexity and variety of different quantitative imaging modalities, such as computed (CT), (MRI), (ICA), intravascular ultrasound (IVUS), and (OCT), necessitated a comprehensive clinical consensus.

AI combined with CRISPR precisely controls gene expression

Artificial intelligence can predict on-and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

The study by researchers at New York University, Columbia University, and the New York Genome Center, combines a with CRISPR screens to control the expression of human in different ways—such as flicking a light switch to shut them off completely or by using a dimmer knob to partially turn down their activity. These precise gene controls could be used to develop new CRISPR-based therapies.

CRISPR is a gene editing technology with many uses in biomedicine and beyond, from treating sickle cell anemia to engineering tastier mustard greens. It often works by targeting DNA using an enzyme called Cas9. In recent years, scientists discovered another type of CRISPR that instead targets RNA using an enzyme called Cas13.

Study suggests resistance training can prevent or delay Alzheimer’s disease

Regular physical exercise, such as resistance training, can prevent Alzheimer’s disease, or at least delay the appearance of symptoms, and serves as a simple and affordable therapy for Alzheimer’s patients. This is the conclusion of an article published in Frontiers in Neuroscience by Brazilian researchers affiliated with the Federal University of São Paulo (UNIFESP) and the University of São Paulo (USP).

Although and dementia patients are unlikely to be able to do long daily runs or perform other high-intensity , these activities are the focus for most scientific studies on Alzheimer’s. The World Health Organization (WHO) recommends as the best option to train balance, improve posture and prevent falls. Resistance exercise entails contraction of specific muscles against an external resistance and is considered an essential strategy to increase muscle mass, strength and bone density, and to improve overall body composition, functional capacity and balance. It also helps prevent or mitigate sarcopenia (muscle atrophy), making everyday tasks easier to perform.

To observe the neuroprotective effects of this practice, researchers in UNIFESP’s Departments of Physiology and Psychobiology, and the Department of Biochemistry at USP’s Institute of Chemistry (IQ-USP), conducted experiments involving with a mutation responsible for a buildup of beta-amyloid plaques in the brain. The protein accumulates in the central nervous system, impairs synaptic connections and damages neurons, all of which are features of Alzheimer’s disease.

How to teach AI to imitate human thought and action

Artificial intelligence systems can mimic some aspects of human intelligence with impressive results, including detecting objects, navigating environments, playing chess, or even generating text.

But cloning human behavior has its limitations.
Without backing actions with thought, AI systems can become brittle and make unpredictable mistakes when faced with novel situations.

One recent project by scientists at the University of British Columbia and Vector Institute shows the benefits of getting AI systems to think like humans.

Designing surfaces to improve bone grafts

The field of bone implants has taken incredible strides thanks to technological innovations that allow for stronger grafts that are easier to install. Yet even with these advances, there are still risks involved in such procedures. Implants can be loosened following operations, for example, which can lead to costly surgical revisions that lengthen the recovery process for patients.

New research published in Nature Biomedical Engineering from an interdisciplinary team from Northwestern Engineering’s Center for Advanced Regenerative Engineering (CARE) and Center for Physical Genomics and Engineering (CPGE) could reduce the likelihood of these painful, expensive complications.

Working at the convergence of the physical sciences, biology, surgery, and engineering, the investigators introduced the concept of surface topography-induced chromatin engineering. In a collaboration with The University of Chicago’s Russell R. Reid, MD, Ph.D., and Tong-Chuan He, MD, Ph.D., the team explained how and why to use surfaces to change patterns, validating the method in vivo.

Dr. Aubrey de Grey, Ph.D. — President & Chief Science Officer, Longevity Escape Velocity Foundation

Accelerating Effective Treatments To Prevent And Reverse Human Age-Related Disease — Dr. Aubrey de Grey, Ph.D. — President & Chief Science Officer, Longevity Escape Velocity Foundation (LEVF)


Dr. Aubrey de Grey, Ph.D., is President & Chief Science Officer of the Longevity Escape Velocity (LEV) Foundation (https://www.levf.org/), an organization focused on proactively identifying and addressing the most challenging obstacles on the path to the widespread availability of genuinely effective treatments to prevent and reverse human age-related disease.

Dr. de Grey is internationally recognized as a visionary biomedical gerontologist who devised the Strategies for Engineered Negligible Senescence: a comprehensive set of methods to rejuvenate the human body, thereby preventing age-related ill health and mortality. He has co-founded multiple non-profit organizations – including Methuselah Foundation, SENS Research Foundation, and now LEV Foundation – to specifically enable and accelerate its development and clinical translation.

Dr. de Grey received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively. He is the author of The Mitochondrial Free Radical Theory of Aging (1999), Ending Aging (2007), and a large number of academic papers.

Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the advisory boards of numerous scientific journals and research organizations. He is a prolific speaker who regularly presents at conferences and events world-wide.

/* */